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Background

Results

Results

Serrated polyp (SP) pathophysiology is of great interest, and
examination of colonic stem cell (SC) differentiation and crypt
cell proliferation can provide insight into the natural progression
of SPs. In normal colonic mucosa, SCs can differentiate into
neuroendocrine cells (NEC) that reside in the crypt-base stem
cell niche. SCs also produce rapidly proliferating cells located in
the proliferative compartment in the lower half of the crypt.
Staining for minichromosome maintenance 2 (MCM2)
protein, a component of the DNA helicase involved in the
initiation of DNA replication, is a marker of cellular proliferation
in all cell cycle phases. Chromogranin (CGA) is a marker of
differentiated NECs. Using MCM2 and CGA, we examined these
cell types in SPs: hyperplastic polyps (HP) and sessile serrated
adenomas (SSA) with and without cytologic dysplasia.

Patterns of MCM2 staining in SPs: 100% of HPs, SSAs, and SSAs with
dysplasia showed some degree of positive MCM2 staining throughout the
entire crypt (focal/diffuse full crypt staining). Diffuse full crypt proliferation
was seen in 100% of SSAs with dysplasia, 81% of SSAs, and 64% of HPs.
Surface staining was focal/absent in all polyps.

Graphic and tabular representation of MCM2 and CGA staining patterns in SPs

Table 1. Observed MCM2, CGA staining patterns

A

Objectives
Using immunohistochemistry for MCM2 and CGA:
o Examine the proliferative compartment of SPs
o Assess neuroendocrine cell population in SPs
Goal: Identify potential trends in the proliferative and the
neuroendocrine cell compartments in SP progression compared to
the background normal mucosa

B

C

Figure1A-C, MCM2. Normal colonic mucosa (A) compared to full crypt staining in
HP(B) and SSA (C).

Patterns of MCM2 staining in background normal mucosa: When
present, areas of histologically normal mucosa adjacent to SPs showed
aberrant, full crypt staining of MCM2 in 100% of SSAs with dysplasia and 58%
of SSAs. Adjacent normal mucosa of HPs showed the expected/normal pattern.

Diagram1. Observed MCM2 and CGA staining patterns. (Colors correspond
to categories in Table1; circle size approximates relative proportion within
given group.)

Methods
Immunohistochemistry was performed on 46 paraffin-embedded SPs (11 HPs,
31 SSAs, 4 SSAs with dysplasia) and sections of normal colon using anti-MCM2
antibody (Santa-Cruz, Dallas, TX; 1:200 dilution) and CGA (Dako, Carpinteria,
CA; 1:10 dilution). Staining positivity and distribution in both SP and adjacent
normal colonic mucosa was assessed.

Expected proliferation/differentiation patterns in normal colon:
o positive nuclear MCM2 staining of the lower portion of the colonic crypt
o positive cytoplasmic CGA staining of scattered cells in the lower portion of
the colonic crypt

MCM2 demonstrated 3 major categories of staining:
o expected/normal: staining limited to lower portion of crypt or slightly
expanded

HPs

SSAs

SSAs with dysplasia

Interpretation: SP progression may include extension of the proliferative
compartment (orange and green), expansion of proliferative changes to
surrounding normal mucosa (blue), and loss of NECs (purple).
Figure2, MCM2. SSA with dysplasia (left) and adjacent normal mucosa (right)
showing diffuse MCM2 staining.

Patterns of CGA staining in SPs: HPs and SSAs showed scattered CGApositive cells in the lower crypt (>5 cells per crypt base). 100% of SSAs with
dysplasia and a small subset of SSAs (30%), showed rare to absent CGA
positive cells.

Conclusions
o Expansion of the proliferation compartment and neuroendocrine cell
loss are components of SP development and progression.
o HPs and SSAs show a similar proliferative profile.
o Aberrant cell proliferation cell staining patterns in the normal colonic
mucosa adjacent to SSAs with dysplasia (and a subset of SSAs) suggest
that the colonic microenvironment may play a significant role in SP
progression.

o focal: non-continuous full crypt staining
o diffuse: continuous full crypt staining

CGA demonstrated the following staining patterns:
o present (individual scattered cells)

o Continued exposure/stimulation from a particular microenvironment
may promote SP formation and predisposition to malignancy.

o absent (non-continuous or continuous)
Figure3. CGA, SSA with dysplasia shows rare to absent CGA positive cells.

